For citations:
Sagalova О.I., Adonieva V.S., Zotov S.V., Gusev D.A., Strebkova E.A., Galbraikh R.B., Morozov V.G., Khayertynova I.M., Krasilnikova I.V., Sannikova I.V., Bhagat A., Milenin D.O., Efremova A.P. Effectiveness of Glecaprevir/Pibrentasvir in Patients with Chronic HCV-infection Genotypes 1 to 6 in the real-world settings in Russia (EVEREST study). Journal Infectology. 2023;15(2):47-59. (In Russ.) https://doi.org/10.22625/2072-6732-2023-15-2-47-59
.png)
.png)
Email this article 